IKBKB and Miyoshi myopathy: Similarly, DTP3 displayed far more potent activity in primary MM PCs and far less toxicity to normal cells than the IKKβ inhibitor, PS-1145 (Figures 6C and 6D; Figures S6A and S6B; note the different concentrations of DTP3 and PS-1145 used).